Cargando…
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
BACKGROUND: There is a paucity of information on coronavirus disease 2019 (COVID-19) outcomes in asthmatics. OBJECTIVE: To identify risk factors associated with admission and subsequent mortality among COVID-19–infected asthmatics. METHODS: Adults at our institution with a positive polymerase chain...
Autores principales: | Ferastraoaru, Denisa, Hudes, Golda, Jerschow, Elina, Jariwala, Sunit, Karagic, Merhunisa, de Vos, Gabriele, Rosenstreich, David, Ramesh, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826039/ https://www.ncbi.nlm.nih.gov/pubmed/33495097 http://dx.doi.org/10.1016/j.jaip.2020.12.045 |
Ejemplares similares
-
Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021) -
COVID-19 Infection Outcomes in Inner City Asthmatics Treated with Biologics
por: Hudes, Golda, et al.
Publicado: (2022) -
Fractional Administration of COVID19 Vaccine Induces an Antibody Response
por: Regula, Prudhvi, et al.
Publicado: (2022) -
Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose
por: Regula, Prudhvi, et al.
Publicado: (2022) -
Diagnosing environmental allergies: Comparison of skin-prick, intradermal, and serum specific immunoglobulin E testing
por: Ferastraoaru, Denisa, et al.
Publicado: (2017)